Home › Stocks › BDRX › Changes

Who bought & sold BDRX (Q2 2026)

Funds holding (Q2 2026)8
New positions1
Added1
Reduced6
Exited1

As of Q2 2026, 8 institutional funds reported holding BDRX (BIODEXA PHARMACEUTICALS PLC): 1 opened new positions, 1 added, 6 trimmed and 1 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (1)

Fund Shares Value Weight
Allied Private Wealth LLC New 489 $1.27K 0.0

Added to positions (1)

Fund Shares Value Weight Change
Caitong International Asset Management Co., Ltd 5 $15 — +4 sh (+400.0%)

Reduced positions (6)

Fund Shares Value Weight Change
ARMISTICE CAPITAL, LLC 14.81K $43.09K 0.0 -82.71K sh (-84.8%)
GAMMA Investing LLC 1.20K $3.50K — -12.58K sh (-91.3%)
SBI Securities Co., Ltd. 29 $84 — -122 sh (-80.8%)
UBS Group AG 25 $73 — -102 sh (-80.3%)
Hilton Head Capital Partners, LLC 6 $17 — -24 sh (-80.0%)
RHUMBLINE ADVISERS 3 $8 — -16 sh (-84.2%)

Exited positions (1)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
SABBY MANAGEMENT, LLC Exited 257.47K $159.09K 1.9